XTEK receives new SUAS spare parts order from Australian Defence
ASX-listed international defence industry company XTEK Limited secured a $3.4 million order contract with the Australian Department of Defence for the delivery of spare parts in support of its existing Small Unmanned Aerial Systems (SUAS) fleet.
Additive manufacturing, material market could surpass $183b by 2032 – report says
The market for additive manufacturing (AM) and materials could reach USD 183 billion (AUD 275 billion) by 2032, a 21.2 per cent spike in CAGR, as a result of the growing popularity of 3D printing, according to a market report from Future Market Insights.
Mayne Pharma sells US retail generics portfolio for $134 million
Australian pharmaceutical manufacturing company Mayne Pharma has completed the sale of its US retail generics portfolio to Dr. Reddy’s Laboratories for approximately $134 million.
US Manufacturing PMI inched up to 47.7% in February
The February Manufacturing PMI in the United States of America has registered 47.7 per cent, 0.3 percentage points higher than the 47.4 per cent recorded in January, according to the nation's supply executives in the latest Manufacturing Institute for Supply Management (ISM) Report On Business.
Altech Batteries unveils new specifications for Cerenergy battery products
ASX company Altech Batteries Limited has revealed the preliminary battery specifications for its CERENERGY 60 KWh and 1 MWh GridPack battery products.
Australian Manufacturing PMI in April reaches 35-month low amid weak demand
Weak demand in the Australian manufacturing sector has driven the country’s Purchasing Managers Index (PMI) to a 35-month low, according to the latest data from Judo Bank.
Australian company Novonix to produce battery materials in MENA region
Battery technology company Novonix has partnered with TAQAT Development Company to establish an incorporated joint venture that will produce anode materials needed for manufacturing...
Immuron prepares for diarrhoea-focused clinical trial as US FDA lifts clinical hold
Immuron, an Australia-based biopharmaceutical company, is slated to move forward with the clinical evaluation of a new oral therapeutic targeting Campylobacter and Enterotoxigenic Escherichia coli (ETEC) following approval from the US Food and Drug Administration (FDA).
Australian dairy expects another favourable season with firm milk prices, says Rabobank
Australian dairy manufacturers can look forward to another favourable season in 2023/24, with the industry set for its fourth consecutive profitable year, according to Rabobank's recently released annual Australian Dairy Seasonal Outlook.
Orbital kickstarts UAS engine delivery for Australian Army contract
Orbital UAV has begun the delivery of engine builds for Insitu Pacific’s next-generation tactical UAS for the Australian Army.
Featured Article
Good Design Australia opens entries for 2026 awards
For more than six decades, Good Design Australia has celebrated the power of design to shape innovation, industry, and everyday life. Its flagship program, the Australian Good Design Awards, recognises projects that show how thoughtful design can enhance products, services, systems, and communities.
